Gerber Hans-Peter
Insider CIK 1992979 · STRO Chief Scientific Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| STRO SUTRO BIOPHARMA, INC. | M Exercise deriv | 2026-09-18 | 2026-09-22 | 3,750 | — | $0 | 3,750 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | F Tax w/h | 2026-09-18 | 2026-09-22 | 1,345 | $15.34 | $20.6K | 12,367 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise | 2026-09-18 | 2026-09-22 | 3,750 | — | $0 | 13,712 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise deriv | 2026-09-18 | 2026-09-22 | 3,750 | — | $0 | 3,750 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | F Tax w/h | 2026-09-18 | 2026-09-22 | 1,345 | $15.34 | $20.6K | 12,367 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise | 2026-09-18 | 2026-09-22 | 3,750 | — | $0 | 13,712 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2026-03-02 | 2026-03-03 | 5,000 | — | $0 | 5,000 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise deriv | 2026-03-02 | 2026-03-03 | 2,843 | — | $0 | 8,532 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2026-03-02 | 2026-03-03 | 40,000 | — | $0 | 40,000 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | F Tax w/h | 2026-03-02 | 2026-03-03 | 1,170 | $20.55 | $24.0K | 9,518 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise | 2026-03-02 | 2026-03-03 | 2,843 | — | $0 | 10,688 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise deriv | 2026-03-01 | 2026-03-03 | 1,125 | — | $0 | 2,250 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise | 2026-03-01 | 2026-03-03 | 1,125 | — | $0 | 8,308 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | F Tax w/h | 2026-03-01 | 2026-03-03 | 463 | $20.47 | $9.5K | 7,845 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2025-12-23 | 2025-12-29 | 7,925 | — | $0 | 7,925 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | P Buy | 2025-10-15 | 2025-10-16 | 17,000 | $0.80 | $13.6K | 71,832 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise deriv | 2025-09-18 | 2025-09-22 | 37,500 | — | $0 | 75,000 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | F Tax w/h | 2025-09-18 | 2025-09-22 | 13,417 | $0.90 | $12.1K | 54,832 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise | 2025-09-18 | 2025-09-22 | 37,500 | — | $0 | 68,249 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2025-04-04 | 2025-04-08 | 122,500 | — | $0 | 122,500 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2025-04-04 | 2025-04-08 | 113,750 | — | $0 | 113,750 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise deriv | 2025-03-01 | 2025-03-04 | 11,250 | — | $0 | 33,750 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | F Tax w/h | 2025-03-01 | 2025-03-04 | 4,621 | $1.59 | $7.3K | 30,749 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise | 2025-03-01 | 2025-03-04 | 11,250 | — | $0 | 35,370 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise deriv | 2024-09-18 | 2024-09-20 | 37,500 | — | $0 | 112,500 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | F Tax w/h | 2024-09-18 | 2024-09-20 | 13,380 | $3.95 | $52.9K | 24,120 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise | 2024-09-18 | 2024-09-20 | 37,500 | — | $0 | 37,500 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2024-03-05 | 2024-03-07 | 60,000 | — | $0 | 60,000 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2024-03-05 | 2024-03-07 | 45,000 | — | $0 | 45,000 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2023-09-18 | 2023-09-19 | 175,000 | — | $0 | 175,000 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2023-09-18 | 2023-09-19 | 150,000 | — | $0 | 150,000 | SEC↗ |